LivaNova (LIVN) Free Cash Flow (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.15% |
| Dec 31, 2025 | -19.32% |
| Sep 30, 2025 | 30.15% |
| Jun 30, 2025 | 262.58% |
| Mar 31, 2025 | -80.71% |
| Dec 31, 2024 | 107.94% |
| Sep 30, 2024 | 5.28% |
| Jun 30, 2024 | 770.78% |
| Mar 31, 2024 | -91.27% |
| Dec 31, 2023 | 335.75% |
| Sep 30, 2023 | 139.91% |
| Jun 30, 2023 | -280.51% |
| Mar 31, 2023 | 36.61% |
| Dec 31, 2022 | -67.67% |
| Sep 30, 2022 | 280.80% |
| Jun 30, 2022 | -179.44% |
| Mar 31, 2022 | -20.42% |
| Dec 31, 2021 | 25.21% |
| Sep 30, 2021 | 7.56% |
| Jun 30, 2021 | 70.77% |
| Mar 31, 2021 | -62.97% |
| Dec 31, 2020 | 1,758.81% |
| Sep 30, 2020 | 93.54% |
| Jun 30, 2020 | 75.25% |
| Mar 31, 2020 | -2,181.89% |
| Dec 31, 2019 | 93.92% |
| Sep 30, 2019 | -237.80% |
| Jun 30, 2019 | -549.06% |
| Mar 31, 2019 | -146.97% |
| Dec 31, 2018 | -79.56% |
| Sep 30, 2018 | 82.44% |
| Jun 30, 2018 | 47.82% |
| Mar 31, 2018 | 66.35% |
| Dec 31, 2017 | -73.52% |
| Sep 30, 2017 | 466.77% |
| Jun 30, 2017 | -135.12% |
| Mar 31, 2017 | -18.26% |
| Dec 31, 2016 | 28.08% |
| Oct 18, 2015 | 91.56% |
| Jul 24, 2015 | 113.88% |